Characterization of α1‐adrenoceptor subtypes mediating vasoconstriction in human umbilical vein
Open Access
- 29 January 1999
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 126 (2) , 437-442
Abstract
The present study attempted to characterize pharmacologically the subtypes of α‐adrenoceptors mediating contractions in human umbilical vein (HUV). HUV rings were mounted in isolated organ baths and cumulative concentration‐response curves were constructed for the α‐adrenoceptor agonists phenylephrine and adrenaline. Adrenaline was more potent than phenylephrine (pD2=7.29 and 6.04 respectively). Isoproterenol exhibited no agonism on KCl pre‐contracted HUV rings. Propranolol (1 μM) and rauwolscine (0.1 μM) did not affect the concentration‐response curves to adrenaline. These results demonstrate the lack of involvement of functional β‐ or α2‐adrenoceptors in adrenaline‐induced vasoconstriction. The non subtype selective α1‐adrenoceptor antagonist prazosin was evaluated on phenylephrine and adrenaline concentration‐response curves. The effects of the competitive α1A and α1D‐adrenoceptor antagonists, 5‐methyl urapidil and BMY 7378 and the irreversible α1B selective compound chloroethylclonidine (CEC) were also evaluated on adrenaline concentration‐response curves. The potencies of prazosin against responses mediated by adrenaline (pA2=10.87) and phenylephrine (pA2=10.70) indicate the involvement of prazosin‐sensitive functional α1‐adrenoceptor subtype in vasoconstriction of the HUV. The potencies of 5‐methyl urapidil (pA2=6.70) and BMY 7378 (pA2=7.34) were not consistent with the activation of an α1A‐ or α1D‐adrenoceptor population. Exposure to a relatively low CEC concentration (3 μM) abolished the maximum response to adrenaline suggesting that this response was mediated by an α1B‐adrenoceptor subtype. We conclude that HUV express a prazosin‐sensitive functional α1‐adrenoceptor resembling the α1B‐subtype according with the low pA2 values for both 5‐methyl urapidil and BMY 7378 and the high sensitivity to CEC. British Journal of Pharmacology (1999) 126, 437–442; doi:10.1038/sj.bjp.0702320Keywords
This publication has 24 references indexed in Scilit:
- Bradykinin B1 receptors in human umbilical veinEuropean Journal of Pharmacology, 1997
- α-Adrenoceptors and vascular regulation: Molecular, pharmacologic and clinical correlatesPharmacology & Therapeutics, 1996
- Vascular alpha-1 adrenergic receptor subtypes in the regulation of arterial pressureLife Sciences, 1995
- BMY 7378 is a selective antagonist of the D subtype of α1-adrenoceptorsEuropean Journal of Pharmacology, 1995
- Relaxant effects of benzodiazepines on isolated human umbilical arteries and veinsJournal of Autonomic Pharmacology, 1993
- Species heterogeneity of hepatic α1-adrenoceptors: α1A-, α1B- and α1C-subtypesBiochemical and Biophysical Research Communications, 1992
- Prostacyclin producing activity of human umbilical blood vessels in adrenergic innervated and non-innervated portionsProstaglandins, Leukotrienes and Essential Fatty Acids, 1990
- Lack of innervation of human umbilical cord. An immunohistological and histochemical studyPlacenta, 1990
- 5-Methyl-urapidil discriminates between subtypes of the α1-adrenoceptorEuropean Journal of Pharmacology, 1988
- Neurohistochemical evidence supporting an absence of adrenergic and cholinergic innervation in the human placenta and umbilical cordThe Anatomical Record, 1977